Skip to main
DCGO
DCGO logo

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

DocGo Inc. demonstrates a strong positive outlook due to its projected growth in the hospital segment, which is expected to increase from approximately $200 million in 2024 to $250 million in 2025, primarily driven by advancements in medical transportation and mobile health services. The company's robust logistics platform has resulted in high customer renewal rates and expansion opportunities, particularly with new client acquisition in growing markets like Texas, indicating significant potential for revenue diversification and enhancement. Furthermore, as DocGo shifts resources toward its payor business, management remains optimistic about meeting payor targets and enhancing revenues through care gap visits and preventative care programs, positioning the company favorably for long-term growth in value-based care arrangements.

Bears say

DocGo Inc. has experienced a significant decline in its financial performance, primarily due to disappointing revenue from its Mobile Health Services segment, which fell 52.3% year-over-year and came in 9.9% below estimates. The company has revised its adjusted EBITDA margin expectations downward to approximately 5%, reflecting increased operational expenses associated with transitioning away from migrant-related work and investments in its care gap closure program. The combination of lower-than-expected revenue and operational challenges has resulted in adjusted EBITDA of just $1.1 million, markedly below the estimated $13.4 million, indicating financial instability and a challenging outlook for the company's growth prospects.

DocGo (DCGO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, DocGo (DCGO) has a Strong Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.